<?xml version="1.0" encoding="UTF-8"?>
<ref id="B96-pharmaceuticals-13-00096">
 <label>96.</label>
 <element-citation publication-type="book">
  <person-group person-group-type="author">
   <name>
    <surname>Cascella</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Rajnik</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Cuomo</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Dulebohn</surname>
    <given-names>S.C.</given-names>
   </name>
   <name>
    <surname>Di Napoli</surname>
    <given-names>R.</given-names>
   </name>
  </person-group>
  <source>Features, Evaluation and Treatment Coronavirus (COVID-19)</source>
  <publisher-name>StatPearls</publisher-name>
  <publisher-loc>Treasure Island, FL, USA</publisher-loc>
  <year>2020</year>
  <comment>Available online: 
   <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/32150360" xmlns:xlink="http://www.w3.org/1999/xlink">http://www.ncbi.nlm.nih.gov/pubmed/32150360</ext-link>
  </comment>
  <date-in-citation content-type="access-date" iso-8601-date="2020-04-20">(accessed on 20 April 2020)</date-in-citation>
 </element-citation>
</ref>
